# G02 ChatGPT Response

**Session:** G02 - Small-Sample Inference & Forecasting
**Date:** [YYYY-MM-DD]
**Status:** Pending

---

### Executive summary

The KPSS “contradiction” is resolvable once you line up **(a) which series** and **(b) what KPSS’s null actually is**. In your actual results, KPSS on **ND international migration in levels** is **stat = 0.323, p reported = 0.10 (i.e., p ≥ 0.10)**, so it **does not reject** the **null of level-stationarity** at 5%. The only clear KPSS rejection at 5% in the output is for the **first-differenced ND share series** (**stat ≈ 0.500, p ≈ 0.0417**). So a table showing KPSS rejecting *level* stationarity while the narrative says it does not is most consistent with **variable/specification mixing** (levels vs differences; migration vs share) and/or **mis-starring KPSS because the null was misread**. The unit-root script also uses KPSS with `regression="c"` (level-stationarity), so the text should say that explicitly and note that statsmodels often reports p-values as **0.10 when p ≥ 0.10**.

Scenario arithmetic is **internally reproducible**, but the *labels* in the paper need to match the *implemented rules*. The reported “CBO Full” 2045 value (~19,318) is correct **only because the code holds 2025–2029 at 10% above the ARIMA level** (5,126×1.1=5,638.6) and then applies **8% compounding only from 2030–2045**:
**5,126×1.1×1.08¹⁶ ≈ 19,317.5**. If the paper instead describes “8% annual growth from the 2024 baseline for 2025–2045,” that would be **5,126×1.08²¹ ≈ 25,803**, which is *not* what was done. The “Pre‑2020 Trend” scenario is also consistent *once you note it is anchored to 2019 (634), not 2024*: **634 + 72.43×(2045−2019)=2,517**—hence it can sit below the 2024 observed level without violating arithmetic; it’s a **counterfactual “no‑COVID” path**, not a baseline‑anchored forecast.

Top priority terminology/methodology fixes: (1) rename Monte Carlo “credible intervals” to **simulation-based prediction intervals** (or **percentile prediction intervals**) because nothing Bayesian is being fit; (2) replace strong claims like “random walk without drift” / “optimal ARIMA” with hedged language (“AIC-selected candidate in a tiny sample; treated as a baseline”), especially given **structural-break evidence at 2020/2021** from targeted tests; and (3) stop treating unit-root p-values as identification—ADF/KPSS/PP are **diagnostic** here, not dispositive, and breaks/outliers can mimic I(1).

Bottom line: with **n=15 annual points**, you *can* credibly claim transparent scenario construction, careful uncertainty narration, and defensible forecasting *validation* (rolling-origin backtesting against naive benchmarks). You *cannot* credibly claim you’ve “established” the true integration order or that an AIC-picked ARIMA(0,1,0) reveals the DGP—especially with a COVID-era intervention (2020 = 30). The revision becomes publishable when it (i) aligns the write-up with the actual computations, (ii) adds break-robust framing and COVID handling (intervention/robust errors), and (iii) makes forecasting performance—not asymptotic p-values—the centerpiece.

---

## Downloadable files

1. [Download **kpss_resolution.md**](sandbox:/mnt/data/kpss_resolution.md)
2. [Download **backtesting_spec.md**](sandbox:/mnt/data/backtesting_spec.md)
3. [Download **terminology_corrections.csv**](sandbox:/mnt/data/terminology_corrections.csv)
4. [Download **recommendations.md**](sandbox:/mnt/data/recommendations.md)
